OPC Orthotics Written cheat sheet

Assessment sequence: history (chief complaint, onset, prior devices, comorbidities), then visual/observational gait inspection, then palpation, then goniometric and manual muscle testing, then vascular and neurologic screening.

Range-of-motion deficits are recorded in degrees with the joint in a standard position; contracture is documented as fixed loss, not as weakness.

Manual muscle testing grades: 0 no contraction, 1 trace, 2 active motion with gravity eliminated, 3 antigravity full ROM, 4 against moderate resistance, 5 normal.

Vascular screening: dorsalis pedis and posterior tibial pulses, capillary refill, dependent rubor, and skin temperature; absent pulses plus dependent rubor suggest arterial insufficiency and contraindicate compressive or circumferential designs.

Sensory screening with 10 g monofilament: protective sensation is intact at 1-4 of 10 plantar sites; loss at >=7 sites indicates high ulceration risk and drives total contact or offloading design.

Skin integrity: document lesions, scarring, callus, and previous amputation levels; describe location by anatomical landmark, not by device region.

Limb length discrepancy is measured supine; apparent discrepancy (with pelvis leveling) differs from true discrepancy (tape or block measurement) and the two are recorded separately.

Gait observation records foot contact pattern, stance and swing timing, step and stride symmetry, and trunk compensation; findings are paired with the anatomy that explains them.

Plan goals are written as measurable functional outcomes (for example, brace-assisted ambulation distance, ankle angle at contact) rather than as device names.

Device selection follows from the biomechanical problem: control of a joint requires force application proximal and distal to that joint, so a three-point pressure system is the minimum for angular correction.

Contraindications to be checked before finalizing: fixed deformity that cannot be accommodated, severe arterial insufficiency, non-removable infected or ulcerated tissue at the interface, and inability to don or tolerate the device.

Prescription elements include device type, joint(s) controlled, alignment/ankle angle setting, materials, trim lines, interface/liner, and wearing schedule.

For ankle-foot orthoses, the preset ankle angle (neutral vs plantar-flexed) determines whether the device resists dorsiflexion in swing or blocks plantar flexion at contact.

Offloading plans for neuropathic plantar ulcers specify the contact area, weight-bearing status, and expected duration; total contact casting is the reference standard for plantar neuropathic ulcers.

Scoliosis orthosis planning references curve magnitude and skeletal maturity (Risser sign); bracing aims to halt progression, not to reduce an established curve permanently.

Plan includes a defined review interval and objective outcome measures (pain score, distance, skin condition, functional scale) so follow-up can judge success or trigger revision.

Measurement and casting: capture the limb with the joint in the position the device will hold; mark bony prominences and trim lines on the negative cast or scan.

Positive model modification: relieve bony prominences, build in the desired correction, and preserve the weight-bearing surface; modifications are documented on the model.

Thermoplastic forming temperature and drape are matched to material thickness; overheating degrades the sheet and reduces fatigue life.

Alignment check: the device is placed on a level surface and the patient's joint angles are verified against the prescribed angles before delivery.

Fit criteria at delivery: no red marks that persist after 10-15 minutes of removal, no distal migration, trim lines clear the joint and do not impinge on the opposite limb.

Break-in schedule starts with limited daily wear and increases incrementally; skin is inspected after each wear interval during the first week.

Patient/caregiver education covers donning and doffing, sock/footwear requirements, cleaning, wear schedule, and which symptoms require immediate contact.

Documentation at delivery records device type, serial/lot, fit findings, education provided, and the patient's demonstrated ability to don and doff independently.

Follow-up intervals are set by risk: high-risk (neuropathy, insensate skin, recent ulcer) reviewed within days to weeks; stable patients at 3-6 months and annually.

At each visit assess skin (erythema, breakdown), device integrity (cracks, strap wear, joint function), alignment, and fit relative to any change in limb volume.

Persistent erythema that fades within 15-20 minutes of removal is acceptable; non-fading erythema or any open lesion requires device modification or discontinuation.

Limb volume change (edema, weight change, post-surgical change) alters fit; liners and padding are adjusted before structural revision is considered.

Growth in pediatric patients requires scheduled re-evaluation; devices are typically replaced when length or alignment change exceeds the adjustment range.

Outcome re-measurement uses the same measures set in the plan so change can be compared; document both baseline and current values.

Replacement and repair criteria: structural failure, loss of corrective force, or wear that cannot be resolved by adjustment; repairs are documented with the reason and outcome.

Discharge or transition criteria are documented when goals are met, and the patient is given a plan for when to return.

Documentation for reimbursement must link the diagnosis, the functional deficit, the device provided, and the expected functional gain; each element is separately stated.

The prescription and the delivered device must match; any deviation is documented with clinical justification and communicated to the prescriber.

Inventory control tracks lot/serial numbers so a device can be traced to the patient in a recall; this is a required element of device traceability.

Scheduling and no-show policy, fee schedule, and financial responsibility disclosure are established before service delivery.

Confidentiality of patient records is maintained; records are released only with patient authorization or as required by law.

Staff competency records and equipment calibration logs support the validity of measurements and fabricated devices.

Billing codes describe the device category and its components; modifiers communicate laterality and repair versus replacement.

Quality improvement uses tracked indicators (remake rate, delivery timeliness, patient-reported outcomes) reviewed at defined intervals.

The patient's welfare is the primary obligation; when a conflict exists between financial interest and patient benefit, patient benefit governs.

Scope of practice: provide only services within the individual's training and credentials, and refer when the need exceeds that scope.

Informed consent requires disclosure of the proposed device, alternatives, material risks, and the right to refuse, documented before implementation.

Conflicts of interest (ownership of a supplier, referral incentives, gifts) are disclosed to the patient and employer.

Truthful representation: credentials, device capabilities, and expected outcomes are stated accurately; unsubstantiated claims of benefit are prohibited.

Patient information is kept confidential and used only for the purpose for which it was disclosed, consistent with law and authorization.

Fabrication and billing records must reflect what was actually delivered; misrepresenting materials or services is fraud.

Reporting obligations: suspected abuse, unsafe practice, or impaired colleagues are reported through the appropriate channel; retaliation against a good-faith reporter is prohibited.